L. Deng

发表

Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia.

S. Tu, Ying-zhi He, Zhao Liang, 2015, Leukemia research.

The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia

Yuan-Fei Liu, Xiang-hua Lin, L. Deng, 2017, Acta Pharmacologica Sinica.

Shortening the ex vivo culture of CD19‐specific CAR T‐cells retains potent efficacy against acute lymphoblastic leukemia without CAR T‐cell‐related encephalopathy syndrome or severe cytokine release syndrome

S. Tu, Lung-Ji Chang, Jilong Yang, 2019, American journal of hematology.

The increased expression of miR-146 predicts poor prognosis of immune thrombocytopenia

Yuan-Fei Liu, Xiuju Wang, L. Deng, 2016 .

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

S. Tu, Lung-Ji Chang, Jilong Yang, 2020, Frontiers in Immunology.

A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study

Jie-yu Ye, D. Nie, Li-ping Ma, 2020, Leukemia.

Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial

Yu Wang, S. Tu, Yan Chen, 2022, BMC Medicine.

Eps8 vaccine exerts prophylactic antitumor effects in a murine model: a novel vaccine for breast carcinoma.

Liangning Hu, T. Zhao, Yanjie He, 2013, Molecular medicine reports.

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

Shunqing Wang, A. Xiang, D. Nie, 2022, Journal of Hematology & Oncology.

Ponatinib therapy in recurrent Philadelphia chromosome‐positive central nervous system leukemia with T315I mutation after Allo‐HSCT

Z. Fan, F. Huang, L. Xuan, 2019, International journal of cancer.

Modulation of miR-185-5p expression by EBV-miR-BART6 contributes to developmental differences in ABCG4 gene expression in human megakaryocytes.

Jilong Yang, Xiuju Wang, Xuan Zhou, 2016, The international journal of biochemistry & cell biology.

Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies

S. Tu, L. Deng, Chao-Yang Song, 2016, Bone Marrow Transplantation.

Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis

S. Tu, L. Deng, Chao-Yang Song, 2015, Hematology.

Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells.

Xiuju Wang, L. Deng, Kuo-fu Tseng, 2017, Oncology letters.

Analysis and Clinical Characteristics of 23 Cases of Bone Marrow Necrosis.

Jilong Yang, L. Deng, Jingwen Du, 2020, Clinical lymphoma, myeloma & leukemia.

COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma

Xiaohui Zhu, Longhua Chen, L. Liang, 2021, Clinical and translational medicine.

T Cell Epitope Screening of Epstein-Barr Virus Fusion Protein gB

Y. Zeng, Xiaobing Duan, M. Zeng, 2021, Journal of Virology.

Effect of sorafenib on the outcomes of patients with FLT3‐ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Yu Wang, Xiao-jun Huang, Jie-yu Ye, 2018, Cancer.

Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.

Yuan-Fei Liu, Xiuju Wang, L. Deng, 2018, Cancer biomarkers : section A of Disease markers.

Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies

S. Tu, L. Deng, C. Song, 2015, Bone Marrow Transplantation.

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

Shunqing Wang, Shuangfeng Xie, H. Qu, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.

S. Tu, Yu Wang, Yan Chen, 2020, The Lancet. Oncology.

Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations

Bingshu E. Chen, D. Scott, C. Steidl, 2020, Leukemia & lymphoma.

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients

Jilong Yang, Chunyan Yue, L. Deng, 2021, Drug Design, Development and Therapy.

DDDT_A_338752 4875..4883

Jilong Yang, D. Liang, Chunyan Yue, 2021 .

MiR‐92a mediates AZD6244 induced apoptosis and G1‐phase arrest of lymphoma cells by targeting Bim

Xiaobin Lv, Xiuju Wang, W. Meng, 2014, Cell biology international.

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

S. Tu, Lung-Ji Chang, Jilong Yang, 2018, Blood.

Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation.

Yu Wang, Xiao-jun Huang, Depei Wu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation

Jilong Yang, L. Deng, Jingwen Du, 2021, Leukemia & lymphoma.

Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia

Jie Xiao, Hua Jin, L. Deng, 2022, Journal of internal medicine.

Chryseobacterium indologenes in four patients with leukemia

L. Deng, X. Zhou, M. Li, 2015, Transplant Infectious Disease.

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.

Yu Wang, S. Tu, Yan Chen, 2023, The Lancet. Haematology.

Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid Leukemia

Jie Xiao, Hua Jin, L. Deng, 2022, Blood.

Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study

Yu Wang, S. Tu, Yan Chen, 2023, Signal transduction and targeted therapy.